Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine

NCT03527238 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT03527238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03527238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine
Lead sponsor
University of Florida
Phase
Phase 2
Overall status
Completed
Start date
September 21, 2018
Completion date
August 31, 2021
Enrollment
62 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant, liver transplant